HYDERABAD: The Russian Sputnik V vaccine haS arrived in India following the nod to Hyderabad-based pharmaceutical company, Dr. Reddy's Laboratories to conduct an adaptive phase 2/3 human clinical trial for the vaccine in India.
A video of small containers having the logo of Dr. Reddy's and Sputnik V being unloaded from a vehicle went viral on social media on Wednesday.
When contacted, a senior official of Dr. Reddy's confirmed that the vaccines have arrived in India and said that the clinical trials will also start shortly.
The Russian #SputnikV vaccine for #Covid_19 has reached India & clinical trials are set to begin soon. #coronavirusvaccine @XpressHyderabad @Nilesh_TNIE @KrishnaRaoCHVM @gsvasu_TNIE— The New Indian Express (@NewIndianXpress) November 11, 2020
For more details: https://t.co/bI5wCPYU1i pic.twitter.com/AZSoTQELeT
This coincides with the announcement on the same day by Gamaleya National Research Institute of Epidemiology and Microbiology and Russian Direct Investment Fund, that the Sputnik V vaccine has been found to 92% effective in protecting people against the Covid-19.
As per the information shared by Dr. Reddy's earlier, this will be a multi-center and randomized controlled study which will include safety and immunogenicity study.
In September when Dr. Reddy’s entered into a partnership with the RDIF for the conduct of clinical trials of Sputnik V in India and its distribution here.
As part of the partnership, RDIF will supply 10 crore doses of the vaccine to Dr. Reddy’s upon regulatory approval.